Scientific Study Leader - Biopharmaceuticals Medical, Cardiovascular, Renal And Metabolism (bpm Cvrm)
AstraZeneca
Gothenburg, Sweden
On-site (minimum of three days per week in the office)
Epidemiology and observational research
Evidence generation and strategy
Cross-functional study team collaboration
AstraZeneca is seeking a Scientific Study Leader for its Biopharmaceuticals Medical team in Gothenburg, Sweden, focusing on cardiovascular, renal, and metabolism studies. The ideal candidate will have a doctoral degree in epidemiology or a related field, with substantial experience in the pharmaceutical industry and a strong foundation in epidemiological methodologies
Job Summary
Lead studies for medical evidence generation in close collaboration with other subject experts.
The role is integral throughout the lifecycle of a drug, from drug discovery and development through commercialization.
Shape and execute evidence plans on observational studies aligned with the global medical strategy.
Matching Summary
Match Score: 85
AstraZeneca is seeking a Scientific Study Leader for its Biopharmaceuticals Medical team in Gothenburg, Sweden, focusing on cardiovascular, renal, and metabolism studies. The ideal candidate will have a doctoral degree in epidemiology or a related field, with substantial experience in the pharmaceutical industry and a strong foundation in epidemiological methodologies.
Skills & Requirements
Must-have
Epidemiology and observational research
Evidence generation and strategy
Cross-functional study team collaboration
Scientific Committee coordination
External scientific expert engagement
Nice-to-have
Emerging methodologies and technology
Proactive and strategic scientific leadership
Critical appraisal of study designs
Key Requirements
Doctoral level degree (Ph.D. or equivalent) in epidemiology or related health science field with 5+ years experience
MSc or MPH with substantial experience in healthcare environment or equivalent
Excellent knowledge in epidemiological methodology
Hands-on experience planning, execution, interpretation, and publications